28.64
Liquidia Corp Borsa (LQDA) Ultime notizie
United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle - Barchart.com
Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA) - theglobeandmail.com
Liquidia Shares Drop After Downgrades From Raymond James, BTIG - marketscreener.com
LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path - TradingView
LQDA Downgraded by Raymond James -- Price Target Lowered to $53. - GuruFocus
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback - Zacks Investment Research
Liquidia stock cut to Neutral at BTIG (LQDA:NASDAQ) - Seeking Alpha
Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute - Benzinga
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - TradingView
United Therapeutics Won Its Patent War and Liquidia Collapsed - AOL.com
Liquidia (NASDAQ:LQDA) Shares Gap Down on Analyst Downgrade - MarketBeat
Liquidia Sinks Another 17% as BofA Cuts Target to $40 From $92 After Court Loss - Yahoo Finance
Liquidia Corporation Stock 12‑Month Price Target Cut to $84.43, Implies 179% Upside - TradingView
Liquidia (NASDAQ:LQDA) Stock Price Target Lowered at Needham & Company LLC - MarketBeat
United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia - Benzinga
Raymond James Downgrades Liquidia to Outperform From Buy, $53 Price Target - marketscreener.com
Liquidia Corp (LQDA) Leads September 2026 Healthcare Declines wi - GuruFocus
Raymond James downgrades Liquidia stock rating on patent ruling - Investing.com India
Liquidia Stock Analysis: Post-Ruling Impact and Price Oversold - The Cryptonomist
LQDA Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus
Liquidia stock rating cut to neutral by BTIG on patent ruling - Investing.com UK
BTIG Downgrades Liquidia to Neutral From Buy - marketscreener.com
Why is Liquidia stock down 5% today? - Investing.com
LQDA Maintained by Needham -- Price Target Lowered to $72.00 - GuruFocus
United Therapeutics Surges 13% After Patent Victory Against Liquidia - citybiz
Needham maintains Buy rating on Liquidia, $72 price target - TradingView
United Therapeutics Wins Patent Lawsuit Against Liquidia - marketscreener.com
Liquidia (LQDA) Dropped, So What Is Behind The Sudden Shift? - Simply Wall Street
Why is Liquidia stock plunging? Yutrepia patent case explained - The Economic Times
United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent - TIKR.com
Liquidia Corp. Shares Edge Higher After HoursUnited Therapeutics (NASDAQ:UTHR), Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia - FinancialContent
Liquidia Corp (LQDA) Shares Fall 57.2% -- What GF Score of 70 Te - GuruFocus
Liquidia Loses Bid to Nix United Therapeutics Lung-Drug Patent - Bloomberg Law News
Liquidia slumps after US court rules for United Therapeutics in patent fight - SRN News
Liquidia Corp (LQDA) Shares Plunge Over 57% Following Patent Rul - GuruFocus
Liquidia plunges 57% on litigation update (LQDA:NASDAQ) - Seeking Alpha
United Therapeutics jumps 13% on court ruling (UTHR:NASDAQ) - Seeking Alpha
Why is Liquidia share price falling by nearly 50% today? US federal court ruling linked to lung drug Yutre - The Economic Times
Liquidia Gets Hit By Delaware Patent Ruling - Finimize
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today - TradingView
LQDA Stock Eyes Worst Day Ever After Judge Upholds Two UTHR Patent Claims - Yahoo Finance
Liquidia options activity surges after patent ruling sinks LQDA 48% - Investing.com
Why is Liquidia stock cratering today? By Investing.com - Investing.com Nigeria
LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now? - theglobeandmail.com
Liquidia loses patent infringement case on two claims By Investing.com - Investing.com Nigeria
Liquidia: Bullish On Their Growth Potential Despite YUTREPIA's Legal Tail Risk - Seeking Alpha
Why is Liquidia stock cratering today? - Investing.com
Liquidia shares crater after court rules for United Therapeutics - Investing.com
Liquidia (LQDA) Shares Drop 52% After Delaware Court Patent Ruli - GuruFocus
Liquidia Found to Infringe United Therapeutics Patent in Court Ruling - marketscreener.com
Liquidia (NASDAQ:LQDA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Delaware Court Rules Liquidia (LQDA) Infringed United Therapeuti - GuruFocus
Liquidia plunges after court ruling in United Therapeutics patent fight (LQDA:NASDAQ) - Seeking Alpha
Liquidia loses patent infringement case on two claims - Investing.com
Liquidia Corporation Announces District Court Ruling on United Therapeutics Patent Claims for YUTREPIA - Quiver Quantitative
A court found Liquidia infringed two patent claims. Its inhaled treatment could face limits. - Stock Titan
Liquidia Corp (LQDA) Shares Plunge 25% After Patent Dispute Cour - GuruFocus
Operating margin % of Liquidia Corporation – HAN:LT4 - TradingView
Liquidia (NASDAQ:LQDA) High Growth Momentum Meets a Pre-Breakout Setup - ChartMill
Diluted shares outstanding of Liquidia Corporation – HAN:LT4 - TradingView
Liquidia: high growth, demanding valuation in mid-cap space - Investing.com
EBITDA of Liquidia Corporation – HAN:LT4 - TradingView
Liquidia (NASDAQ:LQDA) Stock Falls 5.8%What's Next? - MarketBeat
Liquidia (Nasdaq:LQDA)Stock Analysis - Simply Wall Street
Is It Too Late to Buy Liquidia Corp (LQDA) After 7.7% Rally? GF Value Says Undervalued - GuruFocus
Liquidia Corporation (LQDA) Surges Nearly 8% Amid Sector Gains o - GuruFocus
Liquidia rises 8% amid broader strength in biotech peers (LQDA:NASDAQ) - Seeking Alpha
Liquidia (NASDAQ:LQDA) Shares Climb 4.2%Time to Buy? - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Stock Rated "Hold" by Wall Street Brokerages - MarketBeat
LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
Is It Too Late to Buy Liquidia Corp (LQDA) After 5.1% Rally? GF Value Says Undervalued - GuruFocus
Liquidia Corporation (LQDA) Stock Forecasts - Yahoo! Finance Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):